Indian Ginseng Market Report 2026

The indian ginseng market size has grown strongly in recent years. It will grow from $0.93 billion in 2025 to $1 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to traditional use of ayurvedic medicine, growing awareness of herbal stress remedies, expansion of dietary supplement consumption, availability of cultivated ashwagandha roots, increasing exports of herbal ingredients.

The indian ginseng market size is expected to see strong growth in the next few years. It will grow to $1.36 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to rising global demand for adaptogenic supplements, increasing integration into functional foods and beverages, expansion of clinical validation studies, growing preference for plant-based wellness products, rising investment in herbal supply chain transparency. Major trends in the forecast period include increasing demand for standardized herbal extracts, rising adoption of organic and traceable ashwagandha, growing preference for stress and wellness supplements, expansion of functional ingredient applications, enhanced focus on quality certification and purity.

The growing demand for natural and herbal products is expected to drive the expansion of the Indian ginseng market in the future. These products are made from plant-based or naturally sourced ingredients and are used for health, wellness, and beauty with minimal processing to maintain their benefits. The increasing demand for natural and herbal products is driven by rising consumer awareness of their health benefits, a growing preference for chemical-free ingredients, and the rise of sustainable and organic products across various industries. Indian ginseng (Ashwagandha) supports the demand for natural and herbal products by promoting stress relief, boosting energy, and enhancing overall wellness, in line with the increasing preference for plant-based, chemical-free solutions. For example, in September 2024, HerbalGram, a U.S.-based nonprofit, reported a 4.4% increase in annual sales of herbal dietary supplements in the U.S., rising from $12.018 billion in 2022 to $12.551 billion in 2023. This trend is driving the growth of the Indian ginseng market.

Key players in the Indian ginseng market are focusing on developing innovative products, such as organic gummies. These gummies are chewable, gelatin- or pectin-based candies made from organic ingredients, including organic sweeteners, natural flavors, and organic fruit extracts. For instance, in August 2023, Himalaya Wellness Company, an India-based pharmaceutical manufacturer, launched Himalaya's plant-based organic ashwagandha gummies. Made with clinically studied KSM-66 Ashwagandha root extract, these gummies help provide stress relief, enhance energy, and improve sleep quality. They are formulated to support adrenal function and balance cortisol levels. Free from gluten, dairy, corn, and soy, they are also USDA organic certified and non-GMO project verified, ensuring a clean and natural supplement option.

In August 2025, Reliance Consumer Products, an India-based FMCG company, acquired a majority stake in Naturedge Beverages Pvt. Ltd. for an undisclosed amount. This acquisition allows Reliance Consumer Products to expand its herbal and functional beverage portfolio, strengthening its presence in the Indian health and wellness market. Naturedge Beverages Pvt. Ltd is an India-based company specializing in Indian ginseng products.

Major companies operating in the indian ginseng market are Herbalife Nutrition, Kabir Lifesciences, Patanjali Ayurved, Botanic Healthcare, Apex International, Organic India Pvt. Ltd., Arjuna Natural Pvt. Ltd, Sabinsa Corporation, Kairali Ayurvedic Group, Himalaya Global Holdings, Baidyanath Group, Medikonda Nutrients, Amway India, Ixoreal Biomed, Uniray Lifesciences, Sandu Pharmaceuticals Ltd, PhytoLife Sciences, Zoic Pharmaceuticals, Charak Pharma Pvt. Ltd, Kshipra Biotech Private Limited, Greenwell Lifesciences, Shree Sai Biotech.

Asia-Pacific was the largest region in the Indian ginseng market in 2025. The regions covered in the indian ginseng market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the indian ginseng market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The Indian ginseng market consists of sales of capsules and tablets, liquid extracts, herbal teas, topical oils and creams, nutraceuticals, and supplements. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.